Related references
Note: Only part of the references are listed.An approach for normalization and quality control for NanoString RNA expression data
Arjun Bhattacharya et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Emerging roles for IL-6 family cytokines as positive and negative regulators of ectopic lymphoid structures
David G. Hill et al.
CYTOKINE (2021)
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
Frances Humby et al.
LANCET (2021)
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus
Roberto Giacomelli et al.
AUTOIMMUNITY REVIEWS (2021)
Fibroblast pathology in inflammatory joint disease
Lucy-Jayne Marsh et al.
IMMUNOLOGICAL REVIEWS (2021)
B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure
F. Rivellese et al.
ARTHRITIS & RHEUMATOLOGY (2020)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
M3C: Monte Carlo reference-based consensus clustering
Christopher R. John et al.
SCIENTIFIC REPORTS (2020)
A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients
Alessandra Nerviani et al.
FRONTIERS IN IMMUNOLOGY (2020)
Notch signalling drives synovial fibroblast identity and arthritis pathology
Kevin Wei et al.
NATURE (2020)
Translating IL-6 biology into effective treatments
Ernest H. Choy et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets
Ashley M. Curran et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Transforming clinical trials in rheumatology: towards patient-centric precision medicine
Costantino Pitzalis et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Predicting treatment response to IL6R blockers in rheumatoid arthritis
Bako Nouri et al.
RHEUMATOLOGY (2020)
Sample size requirements for learning to classify with high-dimensional biomarker panels
Paul McKeigue
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
Frances Humby et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Distinct fibroblast subsets drive inflammation and damage in arthritis
Adam P. Croft et al.
NATURE (2019)
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
Fan Zhang et al.
NATURE IMMUNOLOGY (2019)
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes
Myles J. Lewis et al.
CELL REPORTS (2019)
Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
Gloria Lliso-Ribera et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis
Tamara H. Ramwadhdoebe et al.
RHEUMATOLOGY (2019)
Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts
Nicola Ferrari et al.
NATURE COMMUNICATIONS (2019)
Defining refractory rheumatoid arthritis
Maya H. Buch
ANNALS OF THE RHEUMATIC DISEASES (2018)
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis
Fumitaka Mizoguchi et al.
NATURE COMMUNICATIONS (2018)
Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation
William Stephenson et al.
NATURE COMMUNICATIONS (2018)
Rheumatoid arthritis
Josef S. Smolen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis
Sarah Salomon et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Effectiveness of Targeted Therapy in Patients With Previously Untreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
Pawel Kawalec et al.
CLINICAL BREAST CANCER (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients
S. Kelly et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines
Shuzhao Li et al.
NATURE IMMUNOLOGY (2014)
High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease
Serena Bugatti et al.
RHEUMATOLOGY (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
John D. Isaacs et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Pretreatment synovial transcriptional pro le is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab
Vanessa E. Hogan et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
Hennie G. Raterman et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8α+ Type
Karine Crozat et al.
JOURNAL OF IMMUNOLOGY (2011)
Relationship Between the Type I Interferon Signature and the Response to Rituximab in Rheumatoid Arthritis Patients
Rogier M. Thurlings et al.
ARTHRITIS AND RHEUMATISM (2010)
Prolectin, a Glycan-binding Receptor on Dividing B Cells in Germinal Centers
Sarah A. Graham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers
Barry Bresnihan et al.
JOURNAL OF RHEUMATOLOGY (2009)
The abundant synovial expression of the RANK/RANKL/osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation
Bernard Vandooren et al.
ARTHRITIS AND RHEUMATISM (2008)
Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results
A. Kavanaugh et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment
Y. K. Onno Teng et al.
ARTHRITIS AND RHEUMATISM (2007)
Synovitis score: discrimination between chronic low-grade and high-grade synovitis
V. Krenn et al.
HISTOPATHOLOGY (2006)
Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis
T Iwamoto et al.
RHEUMATOLOGY (2006)
Share Paper
